What is the Computed Tomography (CT) severity index?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The CT severity index is a crucial scoring system for assessing the severity of acute pancreatitis, and it should be calculated as the sum of the grade score (0-4) and the necrosis score (0-6), with higher scores indicating increased morbidity and mortality. The CT severity index is based on findings from a contrast-enhanced CT scan and combines two key components: the Balthazar grade (which evaluates pancreatic inflammation and peripancreatic fluid collections on a scale of A to E) and the extent of pancreatic necrosis (scored as 0,2,4, or 6 points based on the percentage of necrosis) 1. The total score ranges from 0 to 10, with higher scores indicating more severe disease.

Key Components of the CT Severity Index

  • The Balthazar grade evaluates pancreatic inflammation and peripancreatic fluid collections on a scale of A to E, with scores ranging from 0 to 4 1
  • The extent of pancreatic necrosis is scored as 0,2,4, or 6 points based on the percentage of necrosis, with higher scores indicating more extensive necrosis 1

Interpretation of the CT Severity Index

  • A score of 0-3 suggests mild pancreatitis with a mortality risk of approximately 3% and complication rate of 8% 1
  • A score of 4-6 indicates moderate pancreatitis with 6% mortality and 35% complication rates 1
  • A score of 7-10 represents severe pancreatitis with 17% mortality and 92% complication rates 1

Clinical Implications

  • The CT severity index helps clinicians predict outcomes, determine appropriate management strategies, and identify patients who may require more intensive monitoring or intervention 1
  • The scoring system is valuable because it objectively quantifies both inflammatory changes and pancreatic tissue damage, which are the two main pathological processes that drive morbidity and mortality in acute pancreatitis 1

From the Research

CT Severity Index

The CT severity index (CTSI) is a prognostic tool used to assess the severity of acute pancreatitis.

  • It is calculated based on the extent of inflammation and necrosis in the pancreas, as seen on computed tomography (CT) scans 2, 3.
  • The CTSI score ranges from 0 to 10, with higher scores indicating more severe disease 2, 3.
  • Studies have shown that the CTSI is a reliable predictor of outcomes in acute pancreatitis, including morbidity, mortality, and the need for intensive care unit (ICU) admission 2, 3, 4, 5.

Correlation with Clinical Outcomes

The CTSI has been shown to correlate with clinical outcomes in acute pancreatitis, including:

  • Mortality: A higher CTSI score is associated with an increased risk of death 2, 3, 5.
  • Morbidity: A higher CTSI score is associated with an increased risk of complications, such as organ failure and infection 2, 3, 5.
  • ICU admission: A higher CTSI score is associated with an increased need for ICU admission 2, 5.
  • Length of hospital stay: A higher CTSI score is associated with a longer hospital stay 3, 5.

Comparison with Other Scoring Systems

The CTSI has been compared with other scoring systems, such as the modified CT severity index (MCTSI) and the Acute Physiology, Age, and Chronic Health Evaluation (APACHE II) index.

  • Studies have shown that the CTSI and MCTSI are similar in terms of their ability to predict outcomes in acute pancreatitis 4, 5.
  • The CTSI has been shown to be more accurate than the APACHE II index in predicting the need for intervention and pancreatic infection 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.